Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Puppy successfully treated for vitamin D poisoning
Miniature dachshund Margot arrived at the hospital with depression, lethargy and nausea.

Miniature dachshund Margot is recovering after devouring human psoriasis medication.

A puppy has been treated successfully for vitamin D poisoning after eating a human medicine containing a synthetic form of the supplement. 

Miniature dachshund Margot was presented to Davies Veterinary Specialists after gobbling up a tube of Dovonex ointment - a topical cream used to treat psoriasis in humans that contains
calcipotriol, a synthetic derivative of vitamin D.

“We calculated that four-month-old Margot had ingested between 500-1000µg (161µg/kg – 323µg/kg) of calcipotriol,” explained Katherine Clarke, an internal medicine resident at Davies. “Toxicity studies in dogs suggest that 1.8 to 3.6µg /kg /day of calcipotriol can cause disturbances in calcium homeostasis, so it wasn’t surprising that Margot developed evidence of toxicity.” 

Margot arrived at the veterinary hospital with depression, lethargy and nausea. She was also severely hypercalcaemic and mildly azotaemic.

The team initially managed her vitamin D poisoning with prednisolone, furosemide and intravenous fluid therapy. While she did show some clinical improvement, the hypercalcaemia persisted, prompting the addition of pamidronate to her treatment. 

The combination of the treatments resulted in normocalcaemia and resolution of the azotaemia. The furosemide was then stopped, and the intravenous fluid therapy was gradually reduced over a few days; her calcium remained normal. 

Margot was discharged on tapering doses of prednisolone and blood tests were performed before each dose reduction to ensure she remained normocalcaemic. She is now said to be be clinically very well having been off all treatment for a few months, and there are no signs that the vitamin D poisoning has led to any permanent damage. 

“Vitamin D toxicity is relatively rare, although the growing trend in vitamin D supplementation in the human population means that dogs are more likely to have access to this vitamin,” said Katherine. 

“Ingestion of psoriasis cream, either by licking it from the skin of the owner or direct ingestion by chewing the tube, is another well-recognised mechanism of vitamin D toxicity in dogs,” she continued. “The addition of vitamin D (cholecalciferol) to rodenticides is also increasing, ingestion of which would cause the undesirable combination of vitamin D toxicosis and a coagulopathy”.

“The prognosis for vitamin D toxicity is variable with some cases experiencing an acute kidney injury or severe gastrointestinal bleeding due to calcification of the soft tissues. However, with prompt, aggressive treatment the prognosis can be reasonable.”

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.